Literature DB >> 29200980

Locally Advanced Disease and Pelvic Exenterations.

Christos Kontovounisios1,2, Paris Tekkis1,2.   

Abstract

Advanced primary and recurrent colorectal cancer can be successfully treated by experienced, dedicated centers delivering good outcomes with low mortality and morbidity. Development and implementation of a comprehensive referral pathway is to be encouraged. Multidisciplinary team management is essential in the management of this complex group of patients and is associated with significantly more complete preoperative evaluation and more accurate provision of patient information, as well as improved access to the most appropriate individualized management plan. A structured selection process can improve outcomes through standardized approaches to service delivery to provide the highest quality of care.

Entities:  

Keywords:  beyond total mesorectal excision; multidisciplinary management; primary advanced rectal cancer; recurrent rectal cancer

Year:  2017        PMID: 29200980      PMCID: PMC5711537          DOI: 10.1055/s-0037-1606118

Source DB:  PubMed          Journal:  Clin Colon Rectal Surg        ISSN: 1530-9681


  60 in total

1.  Efficacy of chemoradiotherapy on pain relief in patients with intrapelvic recurrence of rectal cancer.

Authors:  Yoshinori Ito; Atsushi Ohtsu; Satoshi Ishikura; Narikazu Boku; Keiji Nihei; Takashi Ogino; Hiroshi Ikeda
Journal:  Jpn J Clin Oncol       Date:  2003-04       Impact factor: 3.019

2.  Outcomes of total pelvic exenteration for colorectal cancer.

Authors:  Minoru Nishio; Chohei Sakakura; Tomoyuki Nagata; Atsushi Miyashita; Takuo Hamada; Hisashi Ikoma; Takeshi Kubota; Masayoshi Nakanishi; Akio Kimura; Daisuke Ichikawa; Syoujirou Kikuchi; Hitoshi Fujiwara; Kazuma Okamoto; Toshiya Ochiai; Yukihito Kokuba; Hiroki Taniguchi; Teruhisa Sonoyama; Akeo Hagiwara; Eigo Otsuji
Journal:  Hepatogastroenterology       Date:  2009 Nov-Dec

3.  Development and external validation of a predictive model for pathological complete response of rectal cancer patients including sequential PET-CT imaging.

Authors:  Ruud G P M van Stiphout; Guido Lammering; Jeroen Buijsen; Marco H M Janssen; Maria Antonietta Gambacorta; Pieter Slagmolen; Maarten Lambrecht; Domenico Rubello; Marcello Gava; Alessandro Giordano; Eric O Postma; Karin Haustermans; Carlo Capirci; Vincenzo Valentini; Philippe Lambin
Journal:  Radiother Oncol       Date:  2010-12-20       Impact factor: 6.280

4.  Preoperative versus postoperative chemoradiotherapy for locally advanced rectal cancer: results of the German CAO/ARO/AIO-94 randomized phase III trial after a median follow-up of 11 years.

Authors:  Rolf Sauer; Torsten Liersch; Susanne Merkel; Rainer Fietkau; Werner Hohenberger; Clemens Hess; Heinz Becker; Hans-Rudolf Raab; Marie-Therese Villanueva; Helmut Witzigmann; Christian Wittekind; Tim Beissbarth; Claus Rödel
Journal:  J Clin Oncol       Date:  2012-04-23       Impact factor: 44.544

5.  Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012.

Authors:  J Ferlay; E Steliarova-Foucher; J Lortet-Tieulent; S Rosso; J W W Coebergh; H Comber; D Forman; F Bray
Journal:  Eur J Cancer       Date:  2013-02-26       Impact factor: 9.162

Review 6.  Pelvic exenteration for rectal cancer: a systematic review.

Authors:  Timothy X Yang; David L Morris; Terence C Chua
Journal:  Dis Colon Rectum       Date:  2013-04       Impact factor: 4.585

7.  Mesorectal excision for rectal cancer.

Authors:  J K MacFarlane; R D Ryall; R J Heald
Journal:  Lancet       Date:  1993-02-20       Impact factor: 79.321

8.  Pelvic exenteration with en bloc iliac vessel resection for lateral pelvic wall involvement.

Authors:  Kirk K S Austin; Michael J Solomon
Journal:  Dis Colon Rectum       Date:  2009-07       Impact factor: 4.585

9.  Quality of life and other patient-reported outcomes following exenteration for pelvic malignancy.

Authors:  J M Young; T Badgery-Parker; L M Masya; M King; C Koh; A C Lynch; A G Heriot; M J Solomon
Journal:  Br J Surg       Date:  2014-01-13       Impact factor: 6.939

10.  Total pelvic exenteration for primary and recurrent malignancies.

Authors:  F T J Ferenschild; M Vermaas; C Verhoef; A C Ansink; W J Kirkels; A M M Eggermont; J H W de Wilt
Journal:  World J Surg       Date:  2009-07       Impact factor: 3.352

View more
  1 in total

1.  Practical Application of Augmented/Mixed Reality Technologies in Surgery of Abdominal Cancer Patients.

Authors:  Vladimir M Ivanov; Anton M Krivtsov; Sergey V Strelkov; Anton Yu Smirnov; Roman Yu Shipov; Vladimir G Grebenkov; Valery N Rumyantsev; Igor S Gheleznyak; Dmitry A Surov; Michail S Korzhuk; Valery S Koskin
Journal:  J Imaging       Date:  2022-06-30
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.